Business Context and Reporting Period
This Form 8-K filing by BioCardia, Inc. (BCDA) is dated April 10, 2026. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with continued listing standards.
Key Financial Metrics
The filing discloses the following specific financial data point:
- Stockholders' Equity: $895,000 as of December 31, 2025.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity beyond the equity figure cited for the listing violation.
Material Changes and Listing Status
BioCardia is no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2.5 million. The company's equity of $895,000 falls significantly below this threshold. Despite this non-compliance, the notice has no immediate effect on the listing or trading of the company's common stock, which continues to trade on the Nasdaq Capital Market under the symbol "BCDA."
Outlook, Risks, and Management Commentary
Compliance Plan: The company has until May 25, 2026, to submit a plan to Nasdaq to regain compliance. If accepted, Nasdaq may grant an extension of up to 180 calendar days from April 10, 2026, to evidence compliance.
Risks and Contingencies: Management notes that there is no assurance the company will be able to submit an acceptable plan, regain compliance within the required periods, or that Nasdaq will grant relief from delisting. If the plan is not accepted, the company may request a hearing before a Nasdaq Hearings Panel.
Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to risks and uncertainties.
Investor Verification Checklist
- Verify the company's ability to raise capital or restructure to meet the $2.5 million equity requirement by May 25, 2026.
- Monitor the submission and Nasdaq's acceptance of the compliance plan.
- Review the most recent Form 10-K for detailed financial condition and historical compliance history.
- Assess the risk of potential delisting if the company fails to regain compliance within the 180-day extension period.